A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-108 in Patients With Onychomycosis
Clinical trial NCT00777868 · COMPLETED
Trial details
- NCT number
- NCT00777868
- Sponsor
- Dow Pharmaceutical Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2009-04-01
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.